During the past decade, Bendigo Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 8 clinical trials were completed, i.e. on average, 29.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bendigo Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 6 trials, followed by "The George Institute" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Sumitomo Pharma Oncology, Inc." with 2 trials sponsored and "University of Melbourne" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bendigo Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 5 trials as a collaborator, "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "Baxter Healthcare Corporation" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator and "Berry Consultants" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Bendigo Hospital" are "Critical Illness" (3 trials), "Severe Sepsis" (2 trials), "Acute Kidney Injury" (1 trials), "Acute Kidney Injury Due to Sepsis" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Bendigo Hospital" in a lesser frequency.

Most popular intervention types in "Bendigo Hospital" are "Drug" (26 trials), "Other" (13 trials), "Biological" (3 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bendigo Hospital" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bendigo Hospital". undefined are not yet recruiting, 13 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bendigo Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bendigo Hospital, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

Bendigo Hospital has several departments that took part in Clinical trials: "Bendigo Hospital; Oncology" - 2 trials